Female sexual arousal disorder: New insights

International Journal of Impotence Research

Volumn 12, Issue , 2000, Pages S152-S157

  Goldstein, I ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Female sexual arousal disorder; Female sexual function and dysfunction

Indexed keywords

ANDROGEN; APOMORPHINE; ARGININE; ESTROGEN; LUBRICATING AGENT; METHYLTESTOSTERONE; PHENTOLAMINE; PRASTERONE; PROSTAGLANDIN E1; SILDENAFIL; TESTOSTERONE; TESTOSTERONE PROPIONATE; VASOACTIVE INTESTINAL POLYPEPTIDE; VASODILATOR AGENT; YOHIMBINE;

AGE; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; EDUCATION; EMOTION; FEMALE; FEMALE SEXUAL DYSFUNCTION; HUMAN; PREVALENCE; PRIORITY JOURNAL; PSYCHOTHERAPY; RISK FACTOR; SEXUAL ABUSE; SEXUAL AROUSAL; SEXUAL BEHAVIOR; SEXUAL FUNCTION; SEXUALLY TRANSMITTED DISEASE; SIDE EFFECT; TREATMENT PLANNING;

FEMALE; GENITALIA, FEMALE; HUMAN; PREVALENCE; RISK FACTORS; SEXUAL DYSFUNCTIONS, PSYCHOLOGICAL;

EID: 0033776916     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900596     Document Type: Article

References (38)

1. Leiblum SR. Definition and classification of female sexual disorders. Int J Impot lies 1998; 10(Suppl 2): S104-S106.
2. Basson R et al. Report of the International Consensus Development Conference on Female Sexual Dysfunction: Definitions and Classifications. The Consensus Panel on Definition and Classification of Female Sexual Dysfunction. J Urol 2000; 163: 888-893.
3. Graziottin A. The biological basis of female sexuality. Int Clin Psychopharmacol 1998; 13(Suppl 6): S15-22.
4. Laumann EO, Gagnon JH, Michael RT, Michaels S. The social organization of sexuality. University of Chicago Press: Chicago, 1994.
5. Laumann EO, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999; 281: 537-544.
6. Read S, King M, Watson J. Sexual dysfunction in primary medical care: Prevalence, characteristics and detection by the general practitioner. J Public Health Med 1997; 19: 387-391.
7. Rosen RC, Taylor JF, Leiblum SR, Bachmann GA. Prevalence of sexual dysfunction in women: Results of a survey study of 329 women in an outpatient gynecological clinic. J Sex Mar Ther 1993; 19: 171-188.
8. Levin RJ. VIP, vagina, chloral and periurethral glans—an update on human female genital arousal. Exp Clin Endocrinol 1991; 98: 61-69.
9. Levin RJ. The mechanisms of human female sexual arousal. Ann liev Sex Res 1992; 3: 1-12.
10. Levin RJ. Sex and the human female reproductive tract — what really happens during and after coitus. Int J Impot Res 1998; 10(Suppl 1): S14-S21.
11. Levin RJ, Wagner G. Haemodynainic changes of the human vagina during sexual arousal assessed l)y a heated oxygen electrode. J Physiol (Lond) 1978; 275: 23P-24P.
12. Levin RJ, Wagner G. Orgasm in women in the laboratory — quantitative studies on duration, intensity, latency, and vaginal blood flow. Arch Sex Behav 1985; 14: 439-449.
13. Park K et al. Vasculogenic female sexual dysfunction: The hemodynamic basis for vaginal engorgement insufficiency and clitoral erectile insufficiency. Int J Impot Res 1997; 9: 27-37.
14. Saddeghi-Nejad et al. Preliminary report on the development of rabbit clitoral smooth muscle cell culture. Int J Impot Res 1998; 10: 165-170.
15. Tarcan T et al. Histomorphometric analysis of age-related structural changes in human clitoral cavernosal tissue. J Urol 1999; 161: 940-944.
16. Park K et al. Characterization of phosphodiesterase activity in human clitoral corpus cavernosuin smooth muscle cells in culture. Biochem Biophys Res Commun 1998; 249: 612-617.
17. Burnett AL et al. Immunohistochemical description of nitric oxide synthase isoforms in human clitoris. J Urol 1997; 158: 75-78.
18. Cocchia D et al. Immunohistochemical study of neuropeptide Y containing fibers in the human clitoris and penis. Cell Biol Int Rep 1990; 14: 865-875.
19. Ottesen B. Vasoactive intestinal peptide as a neurotransmitter in the female genital tract. Am J Obstet Gynecol 1983; 147: 203.
20. Ottesen B et al. Vasoactive intestinal polypeptide and the female genital tract: Relationship to reproductive phase and delivery. Am J Obstet Gynecol 1982; 43: 414-420.
21. Otteson B et al. Vasoactive intestinal polypeptide (VIP) provokes vaginal lubrication in normal women. Peptides 1987; 8: 797-800.
22. Traish AM et al. Development of human and rabbit vaginal smooth muscle cell cultures: Effects of vasoactive agents on intracellular levels of cyclic nucleotides. Mol Cell Biol Res Commun 2000; 2: 131-137.
23. Palle C, Bredkjaer HE, Ottesen B, Fahrenkrug J. Vasoactive intestinal polypeptide and human vaginal blood flow: Comparison between transvaginal and intravenous administration. J Clin Exp Pharm Physiol 1990; 17: 61-68.
24. Goldstein I, Berman J. Vasculogenic female sexual dysfunction: Vaginal engorgement and clitoral erectile insufficiency syndromes. Int J Impot Res 1998; 10(Suppl 2): S84-S90.
25. Wagner G. Aspects of genital physiology and pathology. Seminars Neurol 1992; 12: 87-97.
26. Hoyle CH et al. Innervation of vasculature and microvasculature of the human vagina by NOS and neuropeptide-containing nerves. J Anat 1996: 188: 633-644.
27. Laan E, Everaerd W. Physiological measures of vaginal vasocongestion. Int J Impot Res 1998; 10(Suppl 2): S107-S110.
28. Laan E, van Lunsen RH. Hormones and sexuality in postmenopausal women: A psychophysiological study. J Psychosom Obstet Gynaecol 1997; 18: 126-133.
29. Sarrel PM. Ovarian hormones and vaginal blood flow: Using Laser Doppler velociinetry to measure effects in a clinical trial in post-menopausal women. Int J Impot Res 1998; 10(Suppl 2): S91-93.
30. Morokoff PJ, Heiinan JR. Effects of erotic stimuli on sexually functional and dysfunctional women: Multiple measures before and after sex therapy. Rehav Res Ther 1980; 18: 127-133.
31. Palace EM, Gorzalka BB. The enhancing effects of anxiety on arousal in sexually dysfunctional and functional women. J Abnorm Psychol 1990; 99: 403-411.
32. Meston CM, Gorzalka BB, Wright JM. Inhibition of subjective and physiological sexual arousal in women by clonidine. Psychosom Med 1997; 59: 399-407.
33. Duncan L, Bateman DN. Sexual function in women. Do antihypertensive drugs have an impact? Drug Safety 1993; 8: 225-231.
34. Meston CM, Heiinan JR. Ephedrine-activated physiological sexual arousal in women. Arch Gen Psychiatry 1998; 55: 652-656.
35. Riley AJ, Riley EJ. The effect of labetalol and propranolol on the pressor response to sexual arousal in women. Rr J Clin Pharmacol 1981; 12: 341-344.
36. Coope J. Hormonal and non-hormonal interventions for menopausal symptoms. Maturitas 1996; 23: 159-168.
37. Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990; 75: S26-S30.
38. Semmens JP, Semmens EC. Sexual function and the menopause. Clin Obstet Gynecol 1984; 27: 717-723.